a reduced dose of plasma derived hepatitis b vaccine ( hevac b ) was tested for efficacy in the prevention of perinatal hepatitis b virus ( hbv ) transmission in high risk neonates born from e-antigen positive hbsag carrier mothers .
C0062527
hepatitis b vaccine
C0019163
hepatitis b